24 results on '"Burmaoglu S"'
Search Results
2. Connected health in Europe : where are we today?
- Author
-
Mountford, N., Kessie, T., Quinlan, M., Maher, R., Smolders, R., Van Royen, P., Todorovic, I., Belani, H., Horak, H., Ljubi, I., Stage, J., Lamas, D., Shmorgun, I., Perala-Heape, M., Isomursu, Minna, Managematin, V., Trajkovik, Vladimir, Madevska-Bogdanova, A., Stainov, R., Chouvarda, Ioanna, Dimitrakopoulos, G., Stulman, A., Haddad, Y., Alzbutas, Robertas, Calleja, N., Tilney, Myra Kay, Moen, A., Thygesen, E., Lewandowsk, R., Klichowski, M., Oliveira, P., Machado da Silva, J., Loncar Turukalo, T., Marovic, B., Drusany Staric, K., Cvetkovic, B., Luque, E., Fernandez Luque, L., Burmaoglu, S., Dolu, N., Curcin, V., McLaughlin, J., Caulfield, Brian, University College Dublin, and University College Dublin
- Subjects
Quality Assurance, Health Care -- Methods ,European Network for the Joint Evaluation of Connected Health Technologies (ENJECT) ,Health insurance -- Europe ,Medical care -- Europe -- Evaluation ,Health promotion -- Europe ,Medical care -- Evaluation ,Medical care, Cost of -- Europe ,Internetworking (Telecommunication) - Abstract
This report is based upon work from COST Action (ENJECT TD1405), supported by COST (European Cooperation in Science and Technology)., The survey used in the compilation of the report aimed to develop an understanding of Europe’s readiness to adopt Connected Health/eHealth solutions at both a regional and a European level. Most of the questions were answered at a national level, but some countries reported apparent regional differences. Two MC members from each representative country responded in tandem to a majority of the questions based upon their own knowledge and understanding of the policies and procedures in place in their respective counties to form one cohesive knowledge set. Time was allowed for the referencing of additional reports and input on individual questions. The final result of the report forms the basis for a comprehensive overview of the state of Connected Health readiness not only at a local, but also at a European wide, level., N/A
- Published
- 2016
3. Connected Health in Europe: Where are we today?
- Author
-
Mountford, Nicola, Kessie, Threase, Quinlan, M., Maher, R., Smolders, R., Van Royen, P., Todorovic, I., Belani, H., Horak, H., Ljubi, I., Stage, J., Lamas, D., Shmorgun, I., Perälä-Heape, M., Isomursu, Minna, Managematin, V., Trajkovik, V., Madevska-Bogdanova, A., Stainov, R., Chouvarda, Ioanna, Dimitrakopoulos, G., Stulman, A., Haddad, Y., Alzbutas, R., Calleja, N., Tilney, M., Moen, A., Thygesen, E., Lewandowski, R., Klichowski, M., Oliveira, P., Machado da Silva, J., Loncar Turukalo, T., Marovic, B., Drusany Staric, K., Cvetkovic, B., Luque, E., Fernandez Luque, L., Burmaoglu, S., Dolu, N., Curcin, V., McLaughlin, J., and Caulfield, Brian
- Subjects
Connected health - Abstract
This report, which has grown out of an ENJECT survey of 19 European countries, examines the situation of Connected Health in Europe today. It focuses on creating a clear understanding of the current and developing presence of Connected Health throughout European healthcare systems under five headings: The Policy Environment, Education, Business and Health Models, Interoperability, and The Person. COST (European Cooperation in Science and Technology)
- Published
- 2016
4. Analyzing the Dependency Between National Logistics Performance and Competitiveness: Which Logistics Competence is Core for National Strategy?
- Author
-
Burmaoglu Serhat and Sesen Harun
- Subjects
Logistics ,Strategy ,Competitiveness ,Logistics Capability ,Core Competence ,Business ,HF5001-6182 - Abstract
With the advancements in the strategic management field, logistics management has changed considerably and logistics competency has emerged as a new and important area of research. In this regard, the purpose of this study is to find the core logistics abilities, which enable nations to achieve a competitive advantage in the logistics market. Two different data sets, one from World Economic Forum and the other from the World Bank were used. Cluster and discriminant analysis were used to answer the research questions. The results indicated that while the logistics infrastructure and the customs were absolute in determining a high-competitive country, the logistics competence and the tracking & tracing were the core logistics abilities needed to sustain the competitive advantage in long term. The implications of these results are also discussed.
- Published
- 2011
5. Structure-based inhibition of acetylcholinesterase and butyrylcholinesterase with 2-Aryl-6-carboxamide benzoxazole derivatives: synthesis, enzymatic assay, and in silico studies.
- Author
-
Kuzu B, Alagoz MA, Demir Y, Gulcin I, Burmaoglu S, and Algul O
- Abstract
An important research topic is the discovery of multifunctional compounds targeting different disease-causing components. This research aimed to design and synthesize a series of 2-aryl-6-carboxamide benzoxazole derivatives that inhibit cholinesterases on both the peripheral anionic and catalytic anionic sides. Compounds (7-48) were prepared from 4-amino-3-hydroxybenzoic acid in three steps. The Ellman test, molecular docking with Maestro, and molecular dynamics simulation studies with Desmond were done (Schrodinger, 12.8.117). Compound 36, the most potent compound among the 42 new compounds synthesized, had an inhibitory concentration of IC
50 12.62 nM for AChE and IC50 25.45 nM for BChE (whereas donepezil was 69.3 nM and 63.0 nM, respectively). Additionally, compound 36 had docking values of - 7.29 kcal/mol for AChE and - 6.71 kcal/mol for BChE (whereas donepezil was - 6.49 kcal/mol and - 5.057 kcal/mol, respectively). Furthermore, molecular dynamics simulations revealed that compound 36 is stable in the active gorges of both AChE (average RMSD: 1.98 Å) and BChE (average RMSD: 2.2 Å) (donepezil had average RMSD: 1.65 Å and 2.7 Å, respectively). The results show that compound 36 is a potent, selective, mixed-type dual inhibitor of both acetylcholinesterase and butyrylcholinesterase. It does this by binding to both the catalytically active and peripheral anionic sites of cholinesterases at the same time. These findings show that target compounds may be useful for establishing the structural basis for new anti-Alzheimer agents., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
6. The evolutionary path of medical waste management research: Insights from co-citation and co-word analysis.
- Author
-
Soyler A, Burmaoglu S, and Kidak LB
- Abstract
Over the past decades, medical waste management (MWM) has evolved into a paramount global challenge, intertwining environmental sustainability and public health dimensions. This manuscript traces the paradigm shift from the foundational Basel Convention of 1989 to the significant sway of World Health Organization publications on contemporary debates. Utilizing a mixed approach strategy that blended qualitative and quantitative techniques, the research employed extensive literature review, co-citation and co-word analysis methodologies to ascertain the direction of contemporary trends in MWM. Within the scope of the research findings, current strategies reveal noticeable gaps, especially those that lack sound policy structures, comprehensive insights and effective operational frameworks. Co-citation evaluations spotlight predominant themes in academic references. Foremost among them are the socioeconomic factor, environmental significance, medical waste (MW) stabilization and sustainable society, sequenced by cluster magnitude. Co-word analysis unveils that, despite the long-standing presence of incineration plants, pyrolysis has, since 2016, prioritized environmental considerations. The recycling ethos peaked in 2014, but the sustainability paradigm burgeoned in 2020, with the 'circular economy' gaining momentum in 2021. Emerging trend analysis underscores the mounting significance of circular waste technologies and sustainability as indispensable solutions. Results demonstrate MW advancements and highlight emerging trends shaping the future of the field. The research concludes by accentuating the necessity of global collaborative efforts, integrating cutting-edge technologies and infusing sustainability and circularity tenets into societal frameworks to navigate MWM's intricate landscape. Future research trajectories, including wastewater governance, novel mobile waste disposal strategies and a cyclic waste classification paradigm, are proposed., Competing Interests: Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
7. Design, synthesis, and computational studies of benzimidazole derivatives as new antitubercular agents.
- Author
-
Yalcin-Ozkat G, Ersan RH, Ulger M, Ulger ST, Burmaoglu S, Yildiz I, and Algul O
- Subjects
- Molecular Docking Simulation, Molecular Dynamics Simulation, Benzimidazoles pharmacology, Antitubercular Agents pharmacology, Mycobacterium tuberculosis
- Abstract
The increase in the drug-resistant strains of Mycobacterium tuberculosis has led researchers to new drug targets. The development of new compounds that have effective inhibitory properties with the selective vital structure of Mycobacterium tuberculosis is required in new scientific approaches. The most important of these approaches is the development of inhibitor molecules for Mycobacterium cell wall targets. In this study, first of all, the antitubercular activity of 23 benzimidazole derivatives was experimentally determined. And then molecular docking studies were carried out with 4 different targets: Arabinosyltransferase C (EmbC), Filamentous Temperature Sensitive Mutant Z (FtsZ), Protein Tyrosine Phosphatase B (PtpB), and Decaprenylphosphoryl-β-D-ribose-2'-oxidase (DprE1). It has been determined that benzimidazole derivatives show activity through the DprE1 enzyme. It is known that DprE1, which has an important role in the synthesis of the cell envelope from Arabinogalactan, is also effective in the formation of drug resistance. Due to this feature, the DprE1 enzyme has become an important target for drug development studies. Also, it was chosen as a target for this study. This study aims to identify molecules that inhibit DprE1 for the development of more potent and selective antitubercular drugs. For this purpose, molecular docking studies by AutoDock Vina, and CDOCKER and molecular dynamics (MD) simulations and in silico ADME/Tox analysis were implemented for 23 molecules. The molecules exhibited binding affinity values of less than -8.0 kcal/mol. After determining the compound's anti-TB activities by a screening test, the best-docked results were detected using compounds 20 , 21 , and 30 . It was found that 21 , was the best molecule with its binding affinity value, which was supported by MD simulations and in silico ADME modeling results.Communicated by Ramaswamy H. Sarma.
- Published
- 2023
- Full Text
- View/download PDF
8. Exploring enzyme inhibition profiles of novel halogenated chalcone derivatives on some metabolic enzymes: Synthesis, characterization and molecular modeling studies.
- Author
-
Anil DA, Polat MF, Saglamtas R, Tarikogullari AH, Alagoz MA, Gulcin I, Algul O, and Burmaoglu S
- Subjects
- Acetylcholinesterase metabolism, Butyrylcholinesterase metabolism, Carbonic Anhydrase Inhibitors chemistry, Cholinesterase Inhibitors chemistry, Humans, Molecular Docking Simulation, Molecular Structure, Structure-Activity Relationship, Chalcone, Chalcones
- Abstract
Enzyme inhibition is a very active area of research in drug design and development. Chalcone derivatives have a broad enzyme inhibitory activity and function as potential molecules in the development of new drugs. In this study, the synthesized novel halogenated chalcones with bromobenzyl and methoxyphenyl moieties were evaluated toward the acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes and human erythrocyte carbonic anhydrase I (hCA I), and II (hCA II) isoenzymes. They showed highly potent inhibition ability toward AChE with Ki values of 1.83 ± 0.21-11.19 ± 0.96 nM and BChE with Ki values of 3.35 ± 0.91-26.70 ± 4.26 nM; hCA I with Ki values of 29.41 ± 3.14-57.63 ± 4.95 nM, and hCA II with Ki values of 24.00 ± 5.39-54.74 ± 1.65 nM. Among the tested enzyme inhibitions, compounds 14 and 13 were the most active compounds against AChE and BChE. Docking studies were performed to the most active compounds against AChE, BChE, hCA I and hCA II to propose a binding mode in the active site and molecular dynamics simulations were studied to check the molecular interactions and the stability of the ligands in the active site. The results may contribute to the development of new drugs particularly to treat some global disorders including Alzheimer's disease (AD), glaucoma, and diabetes., Competing Interests: Declaration of Competing Interest There is no conflict of interest., (Copyright © 2022 Elsevier Ltd. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
9. Design, synthesis and in vitro antiproliferation activity of some 2-aryl and -heteroaryl benzoxazole derivatives.
- Author
-
Kuzu B, Hepokur C, Turkmenoglu B, Burmaoglu S, and Algul O
- Subjects
- Apoptosis, Benzoxazoles pharmacology, Cell Line, Tumor, Cell Proliferation, Dose-Response Relationship, Drug, Drug Screening Assays, Antitumor, Humans, Molecular Docking Simulation, Molecular Structure, Oxazoles, Structure-Activity Relationship, Antineoplastic Agents pharmacology
- Abstract
Background: Phortress produces reactive electrophilic metabolites that form DNA adducts only in sensitive tumor cells. The authors converted the 2-phenylbenzothiazole nucleus in phortress to 2-aryl and -heteroaryl benzoxazole derivatives (11 new and 14 resynthesized). All synthesized compounds were studied for antitumor activity in various cancer cells. Materials & methods: Cytotoxicity, cell morphology, flow cytometry and cell-cycle analyses of compounds were performed and more active derivatives were tested in the MCF-7 cell line. Conclusion: Methyl 2-(thiophen-2-yl)benzo[d]oxazole-6-carboxylate ( BK89 ) has a higher effect than fluorouracil to induce apoptotic cell death (apoptosis value of 49.44%). Cell-cycle analysis shows that the compounds BK89 and methyl 2-(furan-2-yl)benzo[d]oxazole-6-carboxylate ( BK82 ) can be used as potential cell-cycle blockers by arresting MCF-7 cells in G0/G1 phase at rates of 63% and 85%, respectively.
- Published
- 2022
- Full Text
- View/download PDF
10. Design, synthesis and antiproliferative activity evaluation of fluorine-containing chalcone derivatives.
- Author
-
Burmaoglu S, Aktas Anil D, Gobek A, Kilic D, Yetkin D, Duran N, and Algul O
- Subjects
- Apoptosis, Cell Line, Tumor, Cell Proliferation, Drug Design, Drug Screening Assays, Antitumor, Fluorine pharmacology, HEK293 Cells, Humans, Molecular Docking Simulation, Structure-Activity Relationship, Antineoplastic Agents chemistry, Chalcone chemistry, Chalcone pharmacology, Chalcones chemistry, Chalcones pharmacology
- Abstract
A series of new chalcones containing fluoro atom at B ring have been designed, synthesized, and evaluated to be antiproliferative activity against a panel of human tumor cell lines. Some of the analogs ( 8 , 9 , 12 , 45 , 46 and 48 ) displayed powerful antiproliferative effects to certain human tumor cells, but all of them were devoid of any cytotoxicity towards the normal HEK 293. Acridine orange staining data supported that the cytotoxic and antiproliferative effects of the synthesized analogs on tumor cells are mediated through apoptosis. The compounds 12 and 46 manifested concentration-dependent antiproliferative activity in human hepatocellular carcinoma cell lines using an xCELLigence assay. The structures and antiproliferative activity relationship were further supported by in silico molecular docking study of the compounds against tubulin protein which suggests our compounds interference to cell division. Communicated by Ramaswamy H. Sarma.
- Published
- 2022
- Full Text
- View/download PDF
11. New chalcone derivatives as effective against SARS-CoV-2 agent.
- Author
-
Duran N, Polat MF, Aktas DA, Alagoz MA, Ay E, Cimen F, Tek E, Anil B, Burmaoglu S, and Algul O
- Subjects
- Antiviral Agents pharmacology, Antiviral Agents therapeutic use, Humans, SARS-CoV-2, COVID-19, Chalcone pharmacology, Chalcones pharmacology
- Abstract
Aims: Flavonoids and related compounds, such as quercetin-based antiviral drug Gene-Eden-VIR/Novirin, inhibit the protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The alkylated chalcones isolated from Angelica keiskei inhibit SARS-CoV proteases. In this study, we aimed to compare the anti-SARS CoV-2 activities of both newly synthesized chalcone derivatives and these two drugs., Methods: Determination of the potent antiviral activity of newly synthesized chalcone derivatives against SARS-CoV-2 by calculating the RT-PCR cycling threshold (C
t ) values., Results: Antiviral activities of the compounds varied because of being dose dependent. Compound 6, 7, 9, and 16 were highly effective against SARS-CoV-2 at the concentration of 1.60 µg/mL. Structure-based virtual screening was carried out against the most important druggable SARS-CoV-2 targets, viral RNA-dependent RNA polymerase, to identify putative inhibitors that could facilitate the development of potential anti-coronavirus disease-2019 drug candidates., Conclusions: Computational analyses identified eight compounds inhibiting each target, with binding affinity scores ranging from -4.370 to -2.748 kcal/mol along with their toxicological, ADME, and drug-like properties., (© 2021 John Wiley & Sons Ltd.)- Published
- 2021
- Full Text
- View/download PDF
12. Synthesis and biological evaluation of 3,5-diaryl-pyrazole derivatives as potential antiprostate cancer agents.
- Author
-
Anil D, Caykoylu EU, Sanli F, Gambacorta N, Karatas OF, Nicolotti O, Algul O, and Burmaoglu S
- Subjects
- Antineoplastic Agents chemical synthesis, Antineoplastic Agents chemistry, Cell Line, Tumor, ErbB Receptors metabolism, Humans, Male, Molecular Docking Simulation, PC-3 Cells, Prostatic Neoplasms pathology, Pyrazoles chemical synthesis, Pyrazoles chemistry, Structure-Activity Relationship, Vascular Endothelial Growth Factor Receptor-2, Antineoplastic Agents pharmacology, Prostatic Neoplasms drug therapy, Pyrazoles pharmacology
- Abstract
Prostate cancer is the most frequently diagnosed tumor in men and the second leading cause of cancer-associated mortality in most developed countries. 3,5-Diaryl substituted pyrazole derivatives (20-28) were prepared starting from related chalcones and biologically evaluated for in vitro growth inhibition activity against PC3 and DU145 human prostate cancer cell lines. Compounds 23, 26, and 28 were found to be more potent as compared to the other halogen-substituted derivatives. Especially, the 2-bromo-substituted pyrazole derivative (26) was found to be more potent against PC3 and DU145 cells. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor 2 (VEGFR2) are known to be expressed in DU145 and PC3 cancer cells. The binding mode of the most selective compound 26 toward EGFR and VEGFR2 was investigated by employing docking simulations based on GLIDE standard precision (-5.912 and -6.949 kcal/mol, respectively)., (© 2021 Deutsche Pharmazeutische Gesellschaft.)
- Published
- 2021
- Full Text
- View/download PDF
13. An efficient synthesis of novel di-heterocyclic benzazole derivatives and evaluation of their antiproliferative activities.
- Author
-
Algul O, Ersan RH, Alagoz MA, Duran N, and Burmaoglu S
- Subjects
- Cell Line, Tumor, Cell Proliferation, Drug Screening Assays, Antitumor, HeLa Cells, Hep G2 Cells, Humans, Molecular Docking Simulation, Molecular Structure, Structure-Activity Relationship, Antineoplastic Agents pharmacology
- Abstract
A series of unsymmetrical nine di-heterocyclic compounds of benzazole derivatives were synthesized at one step via cyclization reaction. The compounds evaluated for in vitro cytotoxic activity against A549, A498, HeLa, and HepG2 cancer cell lines. The biological evaluation results show that 23, 26 and 29 exhibit better activity against HepG2 and HeLa cancer cell lines. Compound 23 also showed good activity against A549, and A498 cancer cell lines. The analogs were further performed molecular docking studies against human cytochrome P450 2C8 monooxygenase enzyme, calculated some theoretical quantum parameters, ADMET descriptor and molecular electrostatic potential analysis. The strategy applied in this research work may act as a perspective for the rational design of potential anticancer drugs. Communicated by Ramaswamy H. Sarma.
- Published
- 2021
- Full Text
- View/download PDF
14. Head-to-head bisbenzazole derivatives as antiproliferative agents: design, synthesis, in vitro activity, and SAR analysis.
- Author
-
Ersan RH, Alagoz MA, Ertan-Bolelli T, Duran N, Burmaoglu S, and Algul O
- Abstract
In the present work, a series of bisbenzazole derivatives were designed and synthesized as antiproliferative agents. The antiproliferative activity of these compounds was investigated using MTT assay. Bisbenzazole derivatives showed significant antiproliferative activity against all the four tested cancer cell lines. Among the various bisbenzazole derivatives, bisbenzoxazole derivatives exhibited the most promising anticancer activity followed by bisbenzimidazole and bisbenzothiazole derivatives. All the derivatives were found to be less toxic as compared to methotrexate (positive control) in normal human cells, indicating selective and efficient antiproliferative activity of these bisbenzazole derivatives. The structure-activity relationships of heteroaromatic systems and linkers present in bisbenzazole derivatives were analyzed in detail. In silico ADMET prediction revealed that bisbenzazole is a drug-like small molecule with a favorable safety profile. Compound 31 is a potential antiproliferative hit compound that exhibits unique cytotoxic activity distinct from methotrexate. Twenty-one bisbenzoxazole derivatives have been designed synthesized and evaluated to be an antiproliferative activity against four human tumor cell lines., (© 2020. Springer Nature Switzerland AG.)
- Published
- 2021
- Full Text
- View/download PDF
15. Design, synthesis and biological evaluation of novel bischalcone derivatives as potential anticancer agents.
- Author
-
Burmaoglu S, Gobek A, Aydin BO, Yurtoglu E, Aydin BN, Ozkat GY, Hepokur C, Ozek NS, Aysin F, Altundas R, and Algul O
- Subjects
- Antineoplastic Agents chemical synthesis, Antineoplastic Agents chemistry, Cell Cycle drug effects, Cell Proliferation drug effects, Cell Survival drug effects, Chalcones chemical synthesis, Chalcones chemistry, Dose-Response Relationship, Drug, Drug Screening Assays, Antitumor, Humans, Molecular Docking Simulation, Molecular Structure, Structure-Activity Relationship, Tumor Cells, Cultured, Antineoplastic Agents pharmacology, Chalcones pharmacology, Drug Design
- Abstract
Building on our previous work that discovered chalcone as a promising pharmacophore for anticancer activity, we have various other chalcone derivatives and have synthesized a series of novel bischalcone to explore their anticancer activity. Among all tested compounds, compounds 6a, 6b, and 6c showed the highest antiproliferative activity against A-549 cancer cell lines with the average IC
50 values of 4.18, 4.52, and 5.05 µM, respectively. Moreover, compound 6c showed high antiproliferative activity against the Caco-2 cell line; thus, it was 2- and 4-fold more active than the reference compounds, i.e., methotrexate and capecitabine. Compound 6a also induced cell-cycle arrest in the S phase, whereas compounds 6b and 6c were observed to stop at the G0/G1 phase. Thereafter, we evaluated that compound 6c also had the highest apoptosis/necrosis ratio than other compounds and the standard compound. The anticancer property of the 6c was also supported by molecular docking studies carried out on the EGFR and HER2 receptors. Overall, we expect that these compounds can be further developed for the potential treatment of lung cancer., (Copyright © 2021 Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
16. Synthesis of novel tris-chalcones and determination of their inhibition profiles against some metabolic enzymes.
- Author
-
Burmaoglu S, Yilmaz AO, Polat MF, Kaya R, Gulcin İ, and Algul O
- Subjects
- Carbonic Anhydrase Inhibitors chemistry, Cholinesterase Inhibitors chemistry, Humans, Acetylcholinesterase chemistry, Butyrylcholinesterase chemistry, Carbonic Anhydrase Inhibitors pharmacology, Carbonic Anhydrases chemistry, Chalcones chemical synthesis, Chalcones pharmacology, Cholinesterase Inhibitors pharmacology
- Abstract
In this study, we report the synthesis of novel tris-chalcones and testing of human carbonic anhydrase I, and II isoenzymes (hCA I, and hCA II), acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and α -glycosidase ( α -Gly) inhibitors for the development of novel chalcone structures towards for treatment of some diseases. The compounds demonstrated K
i -Gly enzymes. The results revealed that novel tris-chalcones can have promising drug potential for glaucoma, leukaemia, epilepsy; Alzheimer's disease that was associated with the high enzymatic activity of hCA I, hCA II, AChE, and BChE enzymes.α -Gly enzymes. The results revealed that novel tris-chalcones can have promising drug potential for glaucoma, leukaemia, epilepsy; Alzheimer's disease that was associated with the high enzymatic activity of hCA I, hCA II, AChE, and BChE enzymes.- Published
- 2021
- Full Text
- View/download PDF
17. Design, synthesis and biological evaluation of 3,5-diaryl isoxazole derivatives as potential anticancer agents.
- Author
-
Aktaş DA, Akinalp G, Sanli F, Yucel MA, Gambacorta N, Nicolotti O, Karatas OF, Algul O, and Burmaoglu S
- Subjects
- Antineoplastic Agents chemical synthesis, Antineoplastic Agents metabolism, Drug Design, Drug Screening Assays, Antitumor, Humans, Isoxazoles chemical synthesis, Isoxazoles metabolism, Molecular Docking Simulation, PC-3 Cells, Protein Binding, Ribosomal Protein S6 Kinases, 70-kDa metabolism, Antineoplastic Agents pharmacology, Isoxazoles pharmacology
- Abstract
The present study was carried out in the attempt to synthesize a new class of potential anticancer agents comprising eleven compounds (24-34) sharing the 3,5-diarylisoxazole as a core. The chemical structure of the new synthesized compounds was established by IR,
1 H NMR,13 C NMR and elemental analysis. Their biological potential towards prostate cancer was evaluated by using cancer PC3 cells and non-tumorigenic PNT1a cells. Interestingly, compound 26 distinguished from others with a quite high selectivity value that is comparable to 5-FU. The binding mode of 26 towards Ribosomal protein S6 kinase beta-1 (S6K1) was investigated at a molecular level of detail by employing docking simulations based on GLIDE standard precision as well as MM-GBSA calculations., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2020 Elsevier Ltd. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
18. Synthesis, biological evaluation and molecular docking studies of bis-chalcone derivatives as xanthine oxidase inhibitors and anticancer agents.
- Author
-
Burmaoglu S, Ozcan S, Balcioglu S, Gencel M, Noma SAA, Essiz S, Ates B, and Algul O
- Subjects
- Breast Neoplasms pathology, Catalytic Domain, Cell Proliferation, Cell Survival, Female, Humans, Molecular Docking Simulation, Molecular Structure, Structure-Activity Relationship, Tumor Cells, Cultured, Antineoplastic Agents chemical synthesis, Antineoplastic Agents pharmacology, Breast Neoplasms drug therapy, Chalcone chemistry, Enzyme Inhibitors chemical synthesis, Enzyme Inhibitors pharmacology, Xanthine Oxidase antagonists & inhibitors
- Abstract
In this study, a series of B-ring fluoro substituted bis-chalcone derivatives were synthesized by Claisen-Schmidt condensation reactions and evaluated for their ability to inhibit xanthine oxidase (XO) and growth inhibitory activity against MCF-7 and Caco-2 human cancer cell lines, in vitro. According to the results obtained, the bis-chalcone with fluoro group at the 2 (4b) or 2,5-position (4g) of B-ring were found to be potent inhibitors of the enzyme with IC
50 values in the low micromolar range. The effects of these compounds were about 7 fold higher than allopurinol. The binding modes of the bis-chalcone derivatives in the active site of xanthine oxidase were explained using molecular docking calculations. Also, compound 4g and 4h showed in vitro growth inhibitory activity against a panel of two human cancer cell lines 1.9 and 6.8 μM of IC50 values, respectively., (Copyright © 2019 Elsevier Inc. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
19. Connected Health Services: Framework for an Impact Assessment.
- Author
-
Chouvarda I, Maramis C, Livitckaia K, Trajkovik V, Burmaoglu S, Belani H, Kool J, and Lewandowski R
- Subjects
- Europe, Humans, Delivery of Health Care, Integrated, Models, Organizational, Telemedicine
- Abstract
Background: Connected health (CH), as a new paradigm, manages individual and community health in a holistic manner by leveraging a variety of technologies and has the potential for the incorporation of telehealth and integrated care services, covering the whole spectrum of health-related services addressing healthy subjects and chronic patients. The reorganization of services around the person or citizen has been expected to bring high impact in the health care domain. There are a series of concerns (eg, contextual factors influencing the impact of care models, the cost savings associated with CH solutions, and the sustainability of the CH ecosystem) that should be better addressed for CH technologies to reach stakeholders more successfully. Overall, there is a need to effectively establish an understanding of the concepts of CH impact. As services based on CH technologies go beyond standard clinical interventions and assessments of medical devices or medical treatments, the need for standardization and for new ways of measurements and assessments emerges when studying CH impact., Objective: This study aimed to introduce the CH impact framework (CHIF) that serves as an approach to assess the impact of CH services., Methods: This study focused on the subset of CH comprising services that directly address patients and citizens on the management of disease or health and wellness. The CHIF was developed through a multistep procedure and various activities. These included, as initial steps, a literature review and workshop focusing on knowledge elicitation around CH concepts. Then followed the development of the initial version of the framework, refining of the framework with the experts as a result of the second workshop, and, finally, composition and deployment of a questionnaire for preliminary feedback from early-stage researchers in the relevant domains., Results: The framework contributes to a better understanding of what is CH impact and analyzes the factors toward achieving it. CHIF elaborates on how to assess impact in CH services. These aspects can contribute to an impact-aware design of CH services. It can also contribute to a comparison of CH services and further knowledge of the domain. The CHIF is based on 4 concepts, including CH system and service outline, CH system end users, CH outcomes, and factors toward achieving CH impact. The framework is visualized as an ontological model., Conclusions: The CHIF is an initial step toward identifying methodologies to objectively measure CH impact while recognizing its multiple dimensions and scales., (©Ioanna Chouvarda, Christos Maramis, Kristina Livitckaia, Vladimir Trajkovik, Serhat Burmaoglu, Hrvoje Belani, Jan Kool, Roman Lewandowski, The ENJECT Working Group 1 Network. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 03.09.2019.)
- Published
- 2019
- Full Text
- View/download PDF
20. Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and α-glycosidase inhibitors.
- Author
-
Burmaoglu S, Yilmaz AO, Polat MF, Kaya R, Gulcin İ, and Algul O
- Subjects
- Acetylcholinesterase chemistry, Butyrylcholinesterase chemistry, Carbonic Anhydrase I chemistry, Carbonic Anhydrase II chemistry, Carbonic Anhydrase Inhibitors chemical synthesis, Chalcones chemical synthesis, Cholinesterase Inhibitors chemical synthesis, Glycoside Hydrolase Inhibitors chemical synthesis, Humans, Molecular Structure, Carbonic Anhydrase Inhibitors chemistry, Chalcones chemistry, Cholinesterase Inhibitors chemistry, Glycoside Hydrolase Inhibitors chemistry
- Abstract
A novel class of fluoro-substituted tris-chalcones derivatives (5a-5i) was synthesized from phloroglucinol and corresponding benzaldehydes. A three step synthesis method was followed for the production of these tris-chalcone compounds. The structures of the newly synthesized compounds (5a-5i) were confirmed on the basis of IR,
1 H NMR,13 C NMR, and elemental analysis.The compounds' inhibitory activities were tested against human carbonic anhydrase I and II isoenzymes (hCA I and hCA II), acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and α-glycosidase (α-Gly). These chalcone derivatives had Ki values in the range of 19.58-78.73 nM for hCA I, 12.23-41.70 nM for hCA II, 1.09-6.84 nM for AChE, 8.30-32.30 nM for BChE and 0.93 ± 0.20-18.53 ± 5.06 nM against α-glycosidase. These results strongly support the promising nature of the tris-chalcone scaffold as selective carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase, and α-glycosidase inhibitor. Overall, due to these derivatives' inhibitory potential on the tested enzymes, they are promising drug candidates for the treatment of diseases like glaucoma, leukemia, epilepsy; Alzheimer's disease; type-2 diabetes mellitus that are associated with high enzymatic activity of carbonic anhydrase, acetylcholine esterase, butyrylcholinesterase, and α-glycosidase., (Copyright © 2019 Elsevier Inc. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
21. Synthesis and biological evaluation of phloroglucinol derivatives possessing α-glycosidase, acetylcholinesterase, butyrylcholinesterase, carbonic anhydrase inhibitory activity.
- Author
-
Burmaoglu S, Yilmaz AO, Taslimi P, Algul O, Kilic D, and Gulcin I
- Subjects
- Animals, Carbonic Anhydrases isolation & purification, Dose-Response Relationship, Drug, Electrophorus, Enzyme Inhibitors chemical synthesis, Enzyme Inhibitors chemistry, Glycoside Hydrolases metabolism, Horses, Humans, Molecular Docking Simulation, Molecular Structure, Phloroglucinol chemical synthesis, Phloroglucinol chemistry, Structure-Activity Relationship, Acetylcholinesterase metabolism, Butyrylcholinesterase metabolism, Carbonic Anhydrases metabolism, Enzyme Inhibitors pharmacology, Glycoside Hydrolases antagonists & inhibitors, Phloroglucinol pharmacology
- Abstract
A series of novel phloroglucinol derivatives were designed, synthesized, characterized spectroscopically and tested for their inhibitory activity against selected metabolic enzymes, including α-glycosidase, acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and human carbonic anhydrase I and II (hCA I and II). These compounds displayed nanomolar inhibition levels and showed K
i values of 1.14-3.92 nM against AChE, 0.24-1.64 nM against BChE, 6.73-51.10 nM against α-glycosidase, 1.80-5.10 nM against hCA I, and 1.14-5.45 nM against hCA II., (© 2018 Deutsche Pharmazeutische Gesellschaft.)- Published
- 2018
- Full Text
- View/download PDF
22. Design of potent fluoro-substituted chalcones as antimicrobial agents.
- Author
-
Burmaoglu S, Algul O, Gobek A, Aktas Anil D, Ulger M, Erturk BG, Kaplan E, Dogen A, and Aslan G
- Subjects
- Chalcones chemistry, Microbial Sensitivity Tests, Mycobacterium tuberculosis drug effects, Structure-Activity Relationship, Anti-Infective Agents pharmacology, Chalcones pharmacology, Fluorine chemistry
- Abstract
Owing to ever-increasing bacterial and fungal drug resistance, we attempted to develop novel antitubercular and antimicrobial agents. For this purpose, we developed some new fluorine-substituted chalcone analogs (3, 4, 9-15, and 20-23) using a structure-activity relationship approach. Target compounds were evaluated for their antitubercular efficacy against Mycobacterium tuberculosis H37Rv and antimicrobial activity against five common pathogenic bacterial and three common fungal strains. Three derivatives (3, 9, and 10) displayed significant antitubercular activity with IC
50 values of ≤16,760. Compounds derived from trimethoxy substituent scaffolds with monofluoro substitution on the B ring of the chalcone structure exhibited superior inhibition activity compared to corresponding hydroxy analogs. In terms of antimicrobial activity, most compounds (3, 9, 12-14, and 23) exhibited moderate to potent activity against the bacteria, and the antifungal activities of compounds 3, 13, 15, 20, and 22 were comparable to those of reference drugs ampicillin and fluconazole.- Published
- 2017
- Full Text
- View/download PDF
23. Sensing by Smell: Nanoparticle-Enzyme Sensors for Rapid and Sensitive Detection of Bacteria with Olfactory Output.
- Author
-
Duncan B, Le NDB, Alexander C, Gupta A, Yesilbag Tonga G, Yazdani M, Landis RF, Wang LS, Yan B, Burmaoglu S, Li X, and Rotello VM
- Subjects
- Bacteria metabolism, Bacterial Infections microbiology, Biosensing Techniques economics, Humans, Lipase antagonists & inhibitors, Nanoparticles chemistry, Smell, Time Factors, Bacteria isolation & purification, Biosensing Techniques methods, Candida enzymology, Lipase metabolism, Nanoparticles metabolism
- Abstract
We present here a highly efficient sensor for bacteria that provides an olfactory output, allowing detection without the use of instrumentation and with a modality that does not require visual identification. The sensor platform uses nanoparticles to reversibly complex and inhibits lipase. These complexes are disrupted in the presence of bacteria, restoring enzyme activity and generating scent from odorless pro-fragrance substrate molecules. This system provides rapid (15 min) sensing and very high sensitivity (10
2 cfu/mL) detection of bacteria using the human sense of smell as an output.- Published
- 2017
- Full Text
- View/download PDF
24. Synthesis and anti-proliferative activity of fluoro-substituted chalcones.
- Author
-
Burmaoglu S, Algul O, Anıl DA, Gobek A, Duran GG, Ersan RH, and Duran N
- Subjects
- Antineoplastic Agents chemical synthesis, Antineoplastic Agents chemistry, Cell Line, Tumor, Cell Proliferation drug effects, Cell Survival drug effects, Chalcone chemical synthesis, Chalcone chemistry, Dose-Response Relationship, Drug, Drug Screening Assays, Antitumor, Humans, Molecular Structure, Structure-Activity Relationship, Antineoplastic Agents pharmacology, Chalcone pharmacology
- Abstract
A series of novel fluoro-substituted chalcone derivatives have been synthesized. All synthesized compounds were characterized by (1)H nuclear magnetic resonance (NMR), (13)C NMR, and elemental analysis. Their anti-proliferative activities were evaluated against five cancer cells lines, namely, A549, A498, HeLa, A375, and HepG2 using the MTT method. Most of the compounds showed moderate to high activity with IC50 values in the range of 0.029-0.729μM. Of all the synthesized compounds, 10 and 19 exhibited the most potent anti-proliferative activities against cancer cells, and 10 was identified as the most promising compound., (Copyright © 2016 Elsevier Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.